Xanthones with pancreatic lipase inhibitory activity from the pericarps of Garcinia mangostana L. (Guttiferae)

European Journal of Lipid Science and Technology

Volumn 118, Issue 9, 2016, Pages 1416-1421

  Chae, Hee Sung ^a   Kim, Eun Young ^a   Han, Ling ^a   Kim, Na Rae ^a   Lam, Bunthoeun ^a   Paik, Jin Hyub ^b   Yoon, Kee Dong ^c   Choi, Young Hee ^a   Chin, Young Won ^a  

^a Dongguk University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Alpha mangostin; Garcinia mangostana; Orlistat; Pancreatic lipase

Indexed keywords

EID: 84954305514     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.201500516     Document Type: Article

References (32)

1. Cooke, D., Bloom, S., The obesity pipeline: Current strategies in the development of anti-obesity drugs. Nat. Rev. Drug. Discov. 2006, 5, 919–931.
2. Hirko, K. A., Kantor, E. D., Cohen, S. S., Blot, W. J., et al., Body mass index in young adulthood, obesity trajectory, and premature mortality. Am. J. Epidemiol. 2015, 182, 441–450.
3. Carey, M. C., Small, D. M., Bliss, C. M., Lipid digestion and absorption. Annu. Rev. Physiol. 1983, 45, 651–677.
4. Lowe, M. E., Pancreatic triglyceride lipase and colipase: Insights into dietary fat digestion. Gastroenterology 1994, 107, 1524–1536.
5. Magrioti, V., Verger, R., Constantinou-Kokotou, V., Triacylglycerols based on 2-(N-tert-butoxycarbonylamino) oleic acid are potent inhibitors of pancreatic lipase. J. Med. Chem. 2004, 47, 288–291.
6. Drent, M. L., Larsson, I., William-Olsson, T., Quaade, F., et al., Orlistat (Ro 18-0647), a lipase inhibitor, in the treatment of human obesity: A multiple dose study. Int. J. Obes. Relat. Metab. Disord. 1995, 19, 221–226.
7. Finer, N., James, W. P., Kopelman, P. G., Lean, M. E., Williams, G., One-year treatment of obesity: A randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. Int. J. Obes. Relat. Metab. Disord. 2000, 24, 306–313.
8. Chin, Y. W., Kinghorn, A. D., Structural characterization, biological effects, and synthetic studies on xanthones from mangosteen (Garcinia mangostana), a popular botanical dietary supplement. Mini. Rev. Org. Chem. 2008, 5, 355–364.
9. Devi Sampath, P., Vijayaraghavan, K., Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. J. Biochem. Mol. Toxicol. 2007, 21, 336–339.
10. Balunas, M. J., Su, B., Brueggemeier, R. W., Kinghorn, A. D., Xanthones from the botanical dietary supplement mangosteen (Garcinia mangostana) with aromatase inhibitory activity. J. Nat. Prod. 2008, 71, 1161–1166.
11. Sakagami, Y., Iinuma, M., Piyasena, K. G., Dharmaratne, H. R., Antibacterial activity of alpha-mangostin against vancomycin resistant Enterococci (VRE) and synergism with antibiotics. Phytomedicine 2005, 12, 203–208.
12. Shen, Q., Chitchumroonchokchai, C., Thomas, J. L., Gushchina, L. V., et al., Adipocyte reporter assays: Application for identification of anti-inflammatory and antioxidant properties of mangosteen xanthones. Mol. Nutr. Food Res. 2014, 58, 239–247.
13. Quan, X., Wang, Y., Ma, X., Liang, Y., et al., α-Mangostin induces apoptosis and suppresses differentiation of 3T3-L1 cells via inhibiting fatty acid synthase. PLoS ONE 2012, 7, e33376.
14. Chae, H. S., Kim, Y. M., Bae, J. K., Sorchhann, S., et al., Mangosteen extract attenuates the metabolic disorders of high-fat-fed mice by activating AMPK. J. Med. Food. 2015, Epub ahead of print, PMID: 26452017.
15. Choi, Y. H., Bae, J. K., Chae, H. S., Kim, Y. M., et al., α-Mangostin regulates hepatic steatosis and obesity through SirT1-AMPK and PPARγ pathways in high-fat diet-induced obese mice. J. Agric. Food Chem. 2015, 63, 8399–8406.
16. Yamamoto, M., Shimura, S., Itoh, Y., Ohsaka, T., et al., Anti-obesity effects of lipase inhibitor CT-II, an extract from edible herbs, Nomame herba, on rats fed a high-fat diet. Int. J. Obes. 2000, 24, 758–764.
17. Seyedan, A., Alshawsh, M. A., Alshagga, M. A., Koosha, S., Mohamed, Z., Medicinal plants and their inhibitory activities against pancreatic lipase: A review. Evid. Based Complement Alternat. Med. 2015, 2015, 13.
18. Kawaguchi, K., Mizuno, T., Aida, K., Uchino, K., Hesperidin as an inhibitor of lipases from porcine pancreas and Pseudomonas. Biosci. Biotechnol. Biochem. 1997, 61, 102–104.
19. Yang, M. H., Chin, Y. W., Yoon, K. D., Kim, J., Phenolic compounds with pancreatic lipase inhibitory activity from Korean yam (Dioscorea opposita). J. Enzyme Inhib. Med. Chem. 2014, 29, 1–6.
20. Dixon, M., The determination of enzyme inhibitor constants. Biochem. J. 1953, 55, 170–171.
21. Cornish-Bowden, A., A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. Biochem J. 1974, 137, 143–144.
22. Ee, G. C., Daud, S., Taufiq-Yap, Y. H., Ismail, N. H., Rahmani, M., Xanthones from Garcinia mangostana (Guttiferae). Nat. Prod. Res. 2006, 20, 1067–1073.
23. Zarena, A. S., Udaya Sankar, K., Xanthones enriched extracts from mangosteen pericarp obtained by supercritical carbon dioxide process. Sep. Purif. Technol. 2011, 80, 172–178.
24. Sia, G. L., Bennett, G. J., Harrison, L. J., Sim, K. Y., Minor xanthones from the bark of cratoxylum cochinchinense. Phytochemistry 1995, 38, 1521–1528.
25. Bennett, G. J., Harrison, L. J., Sia, G. L., Sim, K. Y., Triterpenoids, tocotrienols and xanthones from the bark of Cratoxylum cochinchinense. Phytochemistry 1993, 32, 1245–1251.
26. Mohamed, G. A., Ibrahim, S. R., Shaaban, M. I., Ross, S. A., Mangostanaxanthones I and II, new xanthones from the pericarp of Garcinia mangostana. Fitoterapia 2014, 98, 215–221.
27. Asai, F., Tosa, H., Tanaka, T., Iinuma, M., A xanthone from pericarps of Garcinia mangostana. Phytochemistry 1995, 39, 943–944.
28. Gopalakrishnan, G., Balaganesan, B., Two novel xanthones from Garcinia mangostana. Fitoterapia 2000, 71, 607–609.
29. Nguyen, L. H., Vo, H. T., Pham, H. D., Connolly, J. D., Harrison, L. J., Xanthones from the bark of Garcinia merguensis. Phytochemistry 2003, 63, 467–470.
30. Nilar, Harrison, L. J., Xanthones from the heartwood of Garcinia mangostana. Phytochemistry 2002, 60, 541–548.
31. Chairungsrilerd, N., Takeuchi, K., Ohizumi, Y., Nozoe, S., Ohta, T., Mangostanol, a prenyl xanthone from Garcinia mangostana. Phytochemistry 1996, 43, 1099–1102.
32. Iinuma, M., Tosa, H., Tanaka, T., Asai, F., et al., Antibacterial activity of xanthones from guttiferaeous plants against methicillin-resistant Staphylococcus aureus. J. Pharm. Pharmacol. 1996, 48, 861–865.